A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer

Clinical trial NCT00088270 · COMPLETED

Trial details

NCT number: NCT00088270
Sponsor: OSI Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Adenoca of the Biliary Tract

Start date: 2004-08-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.